Juan Boriosi, MD, is participating in a clinical trial with Hospira, Inc., entitled, “A Phase III, Randomized, Double-Blind, Dose-Controlled, Multicenter, Study Evaluating the Safety and Efficacy of Dexmedetomidine in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit Subjects”. The Hospira DEX 08-05 study is an industry-initiated study to characterize the loading and maintenance dosing of dexmedetomidine (DEX) by age group in mechanically ventilated pediatric patients. An estimated 175 subjects will be enrolled in 40 investigative sites in the US.